SELLAS Life Sciences Group Inc. (NASDAQ: SLS) Stock Information | RedChip

SELLAS Life Sciences Group Inc. (NASDAQ: SLS) Listen to this Section


$1.32
+0.0450 ( +3.54% ) 646.7K

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Market Data


Open


$1.32

Previous close


$1.27

Volume


646.7K

Market cap


$84.92M

Day range


$1.27 - $1.34

52 week range


$0.50 - $1.90

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 12 Dec 08, 2023
4 Insider transactions 1 Dec 08, 2023
4 Insider transactions 1 Dec 08, 2023
4 Insider transactions 1 Dec 08, 2023
4 Insider transactions 1 Dec 08, 2023
10-q Quarterly Reports 64 Nov 09, 2023
8-k 8K-related 13 Nov 09, 2023
8-k 8K-related 22 Oct 31, 2023
8-k 8K-related 13 Oct 16, 2023
8-k 8K-related 13 Oct 13, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.